Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
Is a |
Ceftriaxone and tazobactam only product in parenteral dose form |
true |
Inferred relationship |
Some |
|
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
Has manufactured dose form |
Powder for solution for injection |
true |
Inferred relationship |
Some |
|
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
Has unit of presentation |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
|
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Ceftriaxone sodium |
true |
Inferred relationship |
Some |
1 |
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Ceftriaxone (substance) |
true |
Inferred relationship |
Some |
1 |
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
This attribute specifies the numerator unit for the presentation strength of a product. |
g |
true |
Inferred relationship |
Some |
1 |
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
This attribute specifies the denominator unit for the presentation strength of a product. |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
1 |
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Tazobactam sodium (substance) |
true |
Inferred relationship |
Some |
2 |
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Tazobactam |
true |
Inferred relationship |
Some |
2 |
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial |
This attribute specifies the denominator unit for the presentation strength of a product. |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
2 |
|